{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:05:22Z","timestamp":1793833522980,"version":"4.6.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T00:00:00Z","timestamp":1467936000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the National Key Technology Research and Development Program of the Ministry of Science and Technology of China","award":["No.2014BAI09B08"],"award-info":[{"award-number":["No.2014BAI09B08"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81372832"],"award-info":[{"award-number":["No. 81372832"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the 973 project","award":["2013CB911004"],"award-info":[{"award-number":["2013CB911004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s10549-016-3902-0","type":"journal-article","created":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T11:28:50Z","timestamp":1467977330000},"page":"455-462","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Comprehensive analysis of BRCA1 and BRCA2 germline mutations in a large cohort of 5931 Chinese women with breast cancer"],"prefix":"10.1007","volume":"158","author":[{"given":"Juan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoqing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tie","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benyao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,8]]},"reference":[{"issue":"7","key":"3902_CR1","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1016\/S1470-2045(13)70567-9","volume":"15","author":"L Fan","year":"2014","unstructured":"Fan L, Strasser-Weippl K, Li JJ et al (2014) Breast cancer in China. Lancet Oncol 15(7):e279\u2013e289. doi: 10.1016\/S1470-2045(13)70567-9","journal-title":"Lancet Oncol"},{"issue":"3","key":"3902_CR2","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1200\/JCO.2014.56.2728","volume":"33","author":"B Kaufman","year":"2015","unstructured":"Kaufman B, Shapira-Frommer R, Schmutzler RK et al (2015) Olaparib monotherapy in patients with advanced cancer and a germline BRCA1\/2 mutation. J Clin Oncol 33(3):244\u2013250. doi: 10.1200\/JCO.2014.56.2728","journal-title":"J Clin Oncol"},{"issue":"9","key":"3902_CR3","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/S1470-2045(11)70214-5","volume":"12","author":"KA Gelmon","year":"2011","unstructured":"Gelmon KA, Tischkowitz M, Mackay H et al (2011) Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study. Lancet Oncol 12(9):852\u2013861. doi: 10.1016\/S1470-2045(11)70214-5","journal-title":"Lancet Oncol"},{"issue":"1","key":"3902_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10549-008-0066-6","volume":"117","author":"W Chen","year":"2009","unstructured":"Chen W, Pan K, Ouyang T et al (2009) BRCA1 germline mutations and tumor characteristics in Chinese women with familial or early-onset breast cancer. Breast Cancer Res Treat 117(1):55\u201360. doi: 10.1007\/s10549-008-0066-6","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"3902_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10549-011-1596-x","volume":"132","author":"J Zhang","year":"2012","unstructured":"Zhang J, Pei R, Pang Z et al (2012) Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer. Breast Cancer Res Treat 132(2):421\u2013428. doi: 10.1007\/s10549-011-1596-x","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"3902_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10549-007-9708-3","volume":"110","author":"WF Li","year":"2008","unstructured":"Li WF, Hu Z, Rao NY et al (2008) The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified. Breast Cancer Res Treat 110(1):99\u2013109. doi: 10.1007\/s10549-007-9708-3","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"3902_CR7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s10549-009-0385-2","volume":"117","author":"A Kwong","year":"2009","unstructured":"Kwong A, Wong LP, Wong HN et al (2009) A BRCA2 founder mutation and seven novel deleterious BRCA mutations in southern Chinese women with breast and ovarian cancer. Breast Cancer Res Treat 117(3):683\u2013686. doi: 10.1007\/s10549-009-0385-2","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"3902_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/ar.22628","volume":"296","author":"W Cao","year":"2013","unstructured":"Cao W, Wang X, Gao Y et al (2013) BRCA1 germ-line mutations and tumor characteristics in eastern Chinese women with familial breast cancer. Anat Rec (Hoboken) 296(2):273\u2013278. doi: 10.1002\/ar.22628","journal-title":"Anat Rec (Hoboken)"},{"issue":"1","key":"3902_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4048\/jbc.2013.16.1.50","volume":"16","author":"J Ou","year":"2013","unstructured":"Ou J, Wu T, Sijmons R et al (2013) Prevalence of BRCA1 and BRCA2 germline mutations in breast cancer women of multiple ethnic region in northwest China. J Breast Cancer 16(1):50\u201354. doi: 10.4048\/jbc.2013.16.1.50","journal-title":"J Breast Cancer"},{"issue":"3","key":"3902_CR10","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s10549-011-1732-7","volume":"130","author":"L Zhang","year":"2011","unstructured":"Zhang L, Chen L, Bacares R et al (2011) BRCA1 R71\u00a0K missense mutation contributes to cancer predisposition by increasing alternative transcript levels. Breast Cancer Res Treat 130(3):1051\u20131056. doi: 10.1007\/s10549-011-1732-7","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"3902_CR11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1136\/jmg.2004.024711","volume":"42","author":"CM Phelan","year":"2005","unstructured":"Phelan CM, Dapic V, Tice B et al (2005) Classification of BRCA1 missense variants of unknown clinical significance. J Med Genet 42(2):138\u2013146. doi: 10.1136\/jmg.2004.024711","journal-title":"J Med Genet"},{"issue":"3","key":"3902_CR12","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/gcc.10221","volume":"37","author":"K Claes","year":"2003","unstructured":"Claes K, Poppe B, Machackova E et al (2003) Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2. Genes Chromosomes Cancer 37(3):314\u2013320. doi: 10.1002\/gcc.10221","journal-title":"Genes Chromosomes Cancer"},{"issue":"10","key":"3902_CR13","first-page":"3144","volume":"7","author":"M Sekine","year":"2001","unstructured":"Sekine M, Nagata H, Tsuji S et al (2001) Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese population. Clin Cancer Res 7(10):3144\u20133150","journal-title":"Clin Cancer Res"},{"issue":"Suppl 1","key":"3902_CR14","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1525-1438.2006.00311.x","volume":"16","author":"N Li","year":"2006","unstructured":"Li N, Zhang X, Cai Y et al (2006) BRCA1 germline mutations in Chinese patients with hereditary breast and ovarian cancer. Int J Gynecol Cancer 16(Suppl 1):172\u2013178. doi: 10.1111\/j.1525-1438.2006.00311.x","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"3902_CR15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1158\/1055-9965.EPI-03-0196","volume":"13","author":"NM Suter","year":"2004","unstructured":"Suter NM, Ray RM, Hu YW et al (2004) BRCA1 and BRCA2 mutations in women from Shanghai China. Cancer Epidemiol Biomark Prev 13(2):181\u2013189","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"9","key":"3902_CR16","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1200\/JCO.2004.04.179","volume":"22","author":"DH Choi","year":"2004","unstructured":"Choi DH, Lee MH, Bale AE et al (2004) Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients. J Clin Oncol 22(9):1638\u20131645. doi: 10.1200\/JCO.2004.04.179","journal-title":"J Clin Oncol"},{"issue":"6","key":"3902_CR17","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/j.1399-0004.2006.00717.x","volume":"70","author":"SH Han","year":"2006","unstructured":"Han SH, Lee KR, Lee DG et al (2006) Mutation analysis of BRCA1 and BRCA2 from 793 Korean patients with sporadic breast cancer. Clin Genet 70(6):496\u2013501. doi: 10.1111\/j.1399-0004.2006.00717.x","journal-title":"Clin Genet"},{"issue":"1","key":"3902_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/GCO.0b013e328332dca3","volume":"22","author":"AW Kurian","year":"2010","unstructured":"Kurian AW (2010) BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications. Curr Opin Obstet Gynecol 22(1):72\u201378. doi: 10.1097\/GCO.0b013e328332dca3","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"4","key":"3902_CR19","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/ijc.10194","volume":"98","author":"ML Leon Matsuda De","year":"2002","unstructured":"De Leon Matsuda ML, Liede A, Kwan E et al (2002) BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines. Int J Cancer 98(4):596\u2013603. doi: 10.1002\/ijc.10194","journal-title":"Int J Cancer"},{"issue":"6","key":"3902_CR20","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/humu.10154","volume":"20","author":"A Liede","year":"2002","unstructured":"Liede A, Narod SA (2002) Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2. Hum Mutat 20(6):413\u2013424. doi: 10.1002\/humu.10154","journal-title":"Hum Mutat"},{"issue":"1","key":"3902_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10549-015-3377-4","volume":"151","author":"E Kang","year":"2015","unstructured":"Kang E, Seong MW, Park SK et al (2015) The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study. Breast Cancer Res Treat 151(1):157\u2013168. doi: 10.1007\/s10549-015-3377-4","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"3902_CR22","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1111\/j.1349-7006.2008.00944.x","volume":"99","author":"K Sugano","year":"2008","unstructured":"Sugano K, Nakamura S, Ando J et al (2008) Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast\/ovarian cancer. Cancer Sci 99(10):1967\u20131976. doi: 10.1111\/j.1349-7006.2008.00944.x","journal-title":"Cancer Sci"},{"issue":"29","key":"3902_CR23","doi-asserted-by":"publisher","first-page":"4752","DOI":"10.1200\/JCO.2008.16.8310","volume":"26","author":"AW Kurian","year":"2008","unstructured":"Kurian AW, Gong GD, Chun NM et al (2008) Performance of BRCA1\/2 mutation prediction models in Asian Americans. J Clin Oncol 26(29):4752\u20134758. doi: 10.1200\/JCO.2008.16.8310","journal-title":"J Clin Oncol"},{"issue":"2","key":"3902_CR24","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1200\/JCO.2011.41.0027","volume":"31","author":"JN Weitzel","year":"2013","unstructured":"Weitzel JN, Clague J, Martir-Negron A et al (2013) Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network. J Clin Oncol 31(2):210\u2013216. doi: 10.1200\/JCO.2011.41.0027","journal-title":"J Clin Oncol"},{"issue":"7","key":"3902_CR25","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1136\/jmedgenet-2015-103672","volume":"53","author":"K Kast","year":"2016","unstructured":"Kast K, Rhiem K, Wappenschmidt B et al (2016) Prevalence of BRCA1\/2 germline mutations in 21 401 families with breast and ovarian cancer. J Med Genet 53(7):465\u2013471. doi: 10.1136\/jmedgenet-2015-103672","journal-title":"J Med Genet"},{"issue":"15","key":"3902_CR26","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.294.15.1925","volume":"294","author":"R Nanda","year":"2005","unstructured":"Nanda R, Schumm LP, Cummings S et al (2005) Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA 294(15):1925\u20131933. doi: 10.1001\/jama.294.15.1925","journal-title":"JAMA"},{"issue":"10","key":"3902_CR27","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1002\/cncr.24200","volume":"115","author":"MJ Hall","year":"2009","unstructured":"Hall MJ, Reid JE, Burbidge LA et al (2009) BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer 115(10):2222\u20132233. doi: 10.1002\/cncr.24200","journal-title":"Cancer"},{"issue":"3","key":"3902_CR28","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/annonc\/mdu559","volume":"26","author":"C Wang","year":"2015","unstructured":"Wang C, Zhang J, Wang Y et al (2015) Prevalence of BRCA1 mutations and responses to neoadjuvant chemotherapy among BRCA1 carriers and non-carriers with triple-negative breast cancer. Ann Oncol 26(3):523\u2013528. doi: 10.1093\/annonc\/mdu559","journal-title":"Ann Oncol"},{"issue":"5","key":"3902_CR29","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1200\/JCO.1998.16.5.1642","volume":"16","author":"M Robson","year":"1998","unstructured":"Robson M, Gilewski T, Haas B et al (1998) BRCA-associated breast cancer in young women. J Clin Oncol 16(5):1642\u20131649","journal-title":"J Clin Oncol"},{"issue":"6","key":"3902_CR30","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/(SICI)1097-0142(20000315)88:6<1393::AID-CNCR17>3.0.CO;2-P","volume":"88","author":"KE Malone","year":"2000","unstructured":"Malone KE, Daling JR, Neal C et al (2000) Frequency of BRCA1\/BRCA2 mutations in a population-based sample of young breast carcinoma cases. Cancer 88(6):1393\u20131402","journal-title":"Cancer"},{"issue":"2","key":"3902_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/jmg.2005.034744","volume":"43","author":"BG Haffty","year":"2006","unstructured":"Haffty BG, Silber A, Matloff E et al (2006) Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women. J Med Genet 43(2):133\u2013137. doi: 10.1136\/jmg.2005.034744","journal-title":"J Med Genet"},{"issue":"16","key":"3902_CR32","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/jnci\/93.16.1215","volume":"93","author":"N Loman","year":"2001","unstructured":"Loman N, Johannsson O, Kristoffersson U et al (2001) Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. J Natl Cancer Inst 93(16):1215\u20131223. doi: 10.1093\/jnci\/93.16.1215","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"3902_CR33","doi-asserted-by":"crossref","first-page":"R6","DOI":"10.1186\/bcr443","volume":"4","author":"VR Yassaee","year":"2002","unstructured":"Yassaee VR, Zeinali S, Harirchi I et al (2002) Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer. Breast Cancer Res 4(4):R6","journal-title":"Breast Cancer Res"},{"issue":"11","key":"3902_CR34","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/jnci\/91.11.943","volume":"91","author":"J Peto","year":"1999","unstructured":"Peto J, Collins N, Barfoot R et al (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91(11):943\u2013949. doi: 10.1093\/jnci\/91.11.943","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"3902_CR35","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/sj.ejhg.5200988","volume":"11","author":"U Hamann","year":"2003","unstructured":"Hamann U, Liu X, Bungardt N et al (2003) Similar contributions of BRCA1 and BRCA2 germline mutations to early-onset breast cancer in Germany. Eur J Hum Genet 11(6):464\u2013467. doi: 10.1038\/sj.ejhg.5200988","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"3902_CR36","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/humu.9188","volume":"22","author":"JI Martinez-Ferrandis","year":"2003","unstructured":"Martinez-Ferrandis JI, Vega A, Chirivella I et al (2003) Mutational analysis of BRCA1 and BRCA2 in Mediterranean Spanish women with early-onset breast cancer: identification of three novel pathogenic mutations. Hum Mutat 22(5):417\u2013418. doi: 10.1002\/humu.9188","journal-title":"Hum Mutat"},{"issue":"6","key":"3902_CR37","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1200\/JCO.20.6.1480","volume":"20","author":"TS Frank","year":"2002","unstructured":"Frank TS, Deffenbaugh AM, Reid JE et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20(6):1480\u20131490. doi: 10.1200\/JCO.20.6.1480","journal-title":"J Clin Oncol"},{"issue":"15","key":"3902_CR38","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/jnci\/90.15.1138","volume":"90","author":"SR Lakhani","year":"1998","unstructured":"Lakhani SR, Jacquemier J, Sloane JP et al (1998) Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 90(15):1138\u20131145. doi: 10.1093\/jnci\/90.15.1138","journal-title":"J Natl Cancer Inst"},{"issue":"21 Suppl","key":"3902_CR39","first-page":"107S","volume":"18","author":"KA Phillips","year":"2000","unstructured":"Phillips KA (2000) Immunophenotypic and pathologic differences between BRCA1 and BRCA2 hereditary breast cancers. J Clin Oncol 18(21 Suppl):107S\u2013112S","journal-title":"J Clin Oncol"},{"issue":"9","key":"3902_CR40","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nrc1431","volume":"4","author":"SA Narod","year":"2004","unstructured":"Narod SA, Foulkes WD (2004) BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 4(9):665\u2013676. doi: 10.1038\/nrc1431","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"3902_CR41","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1005853022804","volume":"47","author":"BA Agnarsson","year":"1998","unstructured":"Agnarsson BA, Jonasson JG, Bjornsdottir IB et al (1998) Inherited BRCA2 mutation associated with high grade breast cancer. Breast Cancer Res Treat 47(2):121\u2013127","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3902-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-016-3902-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3902-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T14:05:13Z","timestamp":1498313113000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-016-3902-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,8]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["3902"],"URL":"https:\/\/doi.org\/10.1007\/s10549-016-3902-0","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,8]]}}}